BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31296889)

  • 1. Integration of machine learning and mechanistic models accurately predicts variation in cell density of glioblastoma using multiparametric MRI.
    Gaw N; Hawkins-Daarud A; Hu LS; Yoon H; Wang L; Xu Y; Jackson PR; Singleton KW; Baxter LC; Eschbacher J; Gonzales A; Nespodzany A; Smith K; Nakaji P; Mitchell JR; Wu T; Swanson KR; Li J
    Sci Rep; 2019 Jul; 9(1):10063. PubMed ID: 31296889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate Patient-Specific Machine Learning Models of Glioblastoma Invasion Using Transfer Learning.
    Hu LS; Yoon H; Eschbacher JM; Baxter LC; Dueck AC; Nespodzany A; Smith KA; Nakaji P; Xu Y; Wang L; Karis JP; Hawkins-Daarud AJ; Singleton KW; Jackson PR; Anderies BJ; Bendok BR; Zimmerman RS; Quarles C; Porter-Umphrey AB; Mrugala MM; Sharma A; Hoxworth JM; Sattur MG; Sanai N; Koulemberis PE; Krishna C; Mitchell JR; Wu T; Tran NL; Swanson KR; Li J
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):418-425. PubMed ID: 30819771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying intra-tumoral genetic heterogeneity of glioblastoma toward precision medicine using MRI and a data-inclusive machine learning algorithm.
    Wang L; Wang H; D'Angelo F; Curtin L; Sereduk CP; Leon G; Singleton KW; Urcuyo J; Hawkins-Daarud A; Jackson PR; Krishna C; Zimmerman RS; Patra DP; Bendok BR; Smith KA; Nakaji P; Donev K; Baxter LC; Mrugała MM; Ceccarelli M; Iavarone A; Swanson KR; Tran NL; Hu LS; Li J
    PLoS One; 2024; 19(4):e0299267. PubMed ID: 38568950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing a Pipeline for Multiparametric MRI-Guided Radiation Therapy: Initial Results from a Phase II Clinical Trial in Newly Diagnosed Glioblastoma.
    Kim MM; Parmar HA; Aryal MP; Mayo CS; Balter JM; Lawrence TS; Cao Y
    Tomography; 2019 Mar; 5(1):118-126. PubMed ID: 30854449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Learning Radiomics for the Assessment of Telomerase Reverse Transcriptase Promoter Mutation Status in Patients With Glioblastoma Using Multiparametric MRI.
    Zhang H; Zhang H; Zhang Y; Zhou B; Wu L; Lei Y; Huang B
    J Magn Reson Imaging; 2023 Nov; 58(5):1441-1451. PubMed ID: 36896953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multiparametric Model for Mapping Cellularity in Glioblastoma Using Radiographically Localized Biopsies.
    Chang PD; Malone HR; Bowden SG; Chow DS; Gill BJA; Ung TH; Samanamud J; Englander ZK; Sonabend AM; Sheth SA; McKhann GM; Sisti MB; Schwartz LH; Lignelli A; Grinband J; Bruce JN; Canoll P
    AJNR Am J Neuroradiol; 2017 May; 38(5):890-898. PubMed ID: 28255030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.
    Zhou M; Chaudhury B; Hall LO; Goldgof DB; Gillies RJ; Gatenby RA
    J Magn Reson Imaging; 2017 Jul; 46(1):115-123. PubMed ID: 27678245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radiomics nomogram based on multiparametric MRI might stratify glioblastoma patients according to survival.
    Zhang X; Lu H; Tian Q; Feng N; Yin L; Xu X; Du P; Liu Y
    Eur Radiol; 2019 Oct; 29(10):5528-5538. PubMed ID: 30847586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma.
    Hu LS; Ning S; Eschbacher JM; Gaw N; Dueck AC; Smith KA; Nakaji P; Plasencia J; Ranjbar S; Price SJ; Tran N; Loftus J; Jenkins R; O'Neill BP; Elmquist W; Baxter LC; Gao F; Frakes D; Karis JP; Zwart C; Swanson KR; Sarkaria J; Wu T; Mitchell JR; Li J
    PLoS One; 2015; 10(11):e0141506. PubMed ID: 26599106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine-learning based radiogenomics analysis of MRI features and metagenes in glioblastoma multiforme patients with different survival time.
    Liao X; Cai B; Tian B; Luo Y; Song W; Li Y
    J Cell Mol Med; 2019 Jun; 23(6):4375-4385. PubMed ID: 31001929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of MR morphologic, diffusion tensor, and perfusion imaging in the classification of brain tumors using machine learning scheme.
    Shrot S; Salhov M; Dvorski N; Konen E; Averbuch A; Hoffmann C
    Neuroradiology; 2019 Jul; 61(7):757-765. PubMed ID: 30949746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioblastoma Pseudoprogression Discrimination Using Multiparametric Magnetic Resonance Imaging, Principal Component Analysis, and Supervised and Unsupervised Machine Learning.
    Thenier-Villa JL; Martínez-Ricarte FR; Figueroa-Vezirian M; Arikan-Abelló F
    World Neurosurg; 2024 Mar; 183():e953-e962. PubMed ID: 38253179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival-relevant high-risk subregion identification for glioblastoma patients: the MRI-based multiple instance learning approach.
    Zhang X; Lu D; Gao P; Tian Q; Lu H; Xu X; He X; Liu Y
    Eur Radiol; 2020 Oct; 30(10):5602-5610. PubMed ID: 32417949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Evaluation of a Multiparametric Deep Learning Model for Glioblastoma Segmentation Using Heterogeneous Magnetic Resonance Imaging Data From Clinical Routine.
    Perkuhn M; Stavrinou P; Thiele F; Shakirin G; Mohan M; Garmpis D; Kabbasch C; Borggrefe J
    Invest Radiol; 2018 Nov; 53(11):647-654. PubMed ID: 29863600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncertainty quantification in the radiogenomics modeling of EGFR amplification in glioblastoma.
    Hu LS; Wang L; Hawkins-Daarud A; Eschbacher JM; Singleton KW; Jackson PR; Clark-Swanson K; Sereduk CP; Peng S; Wang P; Wang J; Baxter LC; Smith KA; Mazza GL; Stokes AM; Bendok BR; Zimmerman RS; Krishna C; Porter AB; Mrugala MM; Hoxworth JM; Wu T; Tran NL; Swanson KR; Li J
    Sci Rep; 2021 Feb; 11(1):3932. PubMed ID: 33594116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic models based on imaging findings in glioblastoma: Human versus Machine.
    Molina-García D; Vera-Ramírez L; Pérez-Beteta J; Arana E; Pérez-García VM
    Sci Rep; 2019 Apr; 9(1):5982. PubMed ID: 30979965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric magnetic resonance imaging features of a canine glioblastoma model.
    Lee S; Choi SH; Cho HR; Koh J; Park CK; Ichikawa T
    PLoS One; 2021; 16(7):e0254448. PubMed ID: 34242365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Glioblastoma Recurrence by Early Changes in the Apparent Diffusion Coefficient Value and Signal Intensity on FLAIR Images.
    Chang PD; Chow DS; Yang PH; Filippi CG; Lignelli A
    AJR Am J Roentgenol; 2017 Jan; 208(1):57-65. PubMed ID: 27726412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.
    Kim M; Jung SY; Park JE; Jo Y; Park SY; Nam SJ; Kim JH; Kim HS
    Eur Radiol; 2020 Apr; 30(4):2142-2151. PubMed ID: 31828414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques.
    Macyszyn L; Akbari H; Pisapia JM; Da X; Attiah M; Pigrish V; Bi Y; Pal S; Davuluri RV; Roccograndi L; Dahmane N; Martinez-Lage M; Biros G; Wolf RL; Bilello M; O'Rourke DM; Davatzikos C
    Neuro Oncol; 2016 Mar; 18(3):417-25. PubMed ID: 26188015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.